+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Meningitis Diagnostic Testing Market (2022-2027) by Test Type, End-users, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis

  • PDF Icon


  • 191 Pages
  • July 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5650779

New innovative technologies such as PCR and next-generation sequencing are presenting market opportunities

The Global Meningitis Diagnostic Testing Market is estimated to be worth USD 62.23 million in 2022, and is expected to reach USD 77.55 million by 2027, growing at a CAGR of 4.5%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentation

The Global Meningitis Diagnostic Testing Market is segmented based on Test Type, End-users, and Geography.
  • By Test Type, the market is classified into Latex Agglutination Tests, Lateral Flow Assay, PCR Assay, ELISA Tests, and Culture Tests.
  • By End-users, the market is classified into Hospitals, and Diagnostic Centers.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, BioFire Diagnostics LLC (bioMérieux SA), Bio-Rad Laboratories, Inc., DiagCor Bioscience Inc. Ltd, ELITechGroup, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

The Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Meningitis Diagnostic Testing Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The Global Meningitis Diagnostic Testing Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.

Why Buy This Report?

  • The report offers a comprehensive evaluation of the Global Meningitis Diagnostic Testing Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel within the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario within the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules & regulations imposed on this sector across various geographies.
  • The report also contains competitive analysis using 'Positioning Quadrants'; a proprietary competitive positioning tool.

Report Highlights

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Meningitis Diagnostic Testing Market

What is the estimated value of the Global Meningitis Diagnostic Testing Market?

The Global Meningitis Diagnostic Testing Market was estimated to be valued at $62.23 Million in 2022.

What is the growth rate of the Global Meningitis Diagnostic Testing Market?

The growth rate of the Global Meningitis Diagnostic Testing Market is 4.5%, with an estimated value of $77.55 Million by 2027.

What is the forecasted size of the Global Meningitis Diagnostic Testing Market?

The Global Meningitis Diagnostic Testing Market is estimated to be worth $77.55 Million by 2027.

Who are the key companies in the Global Meningitis Diagnostic Testing Market?

Key companies in the Global Meningitis Diagnostic Testing Market include Abbott Laboratories, BioFire Diagnostics LLC (bioMérieux SA), Bio, Rad Laboratories, Inc., DiagCor Bioscience Inc. Ltd., ELITechGroup, IMMY, Fast Track Diagnostics Ltd., Nanosphere (Luminex Corporation) and Qnostics.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Proprietary Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Prevalence of Meningitis
4.1.2 Growing Demand for Point-of-Care Services
4.2 Restraints
4.2.1 Complex Regulatory Framework
4.3 Opportunities
4.3.1 Technological Advancement
4.4 Challenges
4.4.1 Lack of Awareness Regarding Diagnosis and Availability of Diagnostic Laboratories
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Meningitis Diagnostic Testing Market, by Test Type
6.1 Introduction
6.2 Latex Agglutination Tests
6.3 Lateral Flow Assay
6.4 PCR Assay
6.5 ELISA Tests
6.6 Culture Tests
7 Global Meningitis Diagnostic Testing Market, by End-users
7.1 Introduction
7.2 Hospitals
7.3 Diagnostic Centers
8 Americas’ Meningitis Diagnostic Testing Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe’s Meningitis Diagnostic Testing Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa’s Meningitis Diagnostic Testing Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC’s Meningitis Diagnostic Testing Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 Abbott Laboratories
13.2 BioFire Diagnostics LLC (bioMérieux SA)
13.3 Bio-Rad Laboratories, Inc.
13.4 DiagCor Bioscience Inc. Ltd.
13.5 ELITechGroup
13.6 IMMY
13.7 Fast Track Diagnostics Ltd.
13.8 Nanosphere (Luminex Corporation)
13.9 Qnostics
13.10 Seegene Inc.
13.11 Siemens Healthineers AG
13.12 Thermo Fisher Scientific, Inc.
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • BioFire Diagnostics LLC (bioMérieux SA)
  • Bio-Rad Laboratories, Inc.
  • DiagCor Bioscience Inc. Ltd.
  • ELITechGroup
  • IMMY
  • Fast Track Diagnostics Ltd.
  • Nanosphere (Luminex Corporation)
  • Qnostics
  • Seegene Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.